J&J has beaten EPS expectations for 18 quarters, but the stock has underperformed its peers and the broader market this year Johnson & Johnson is scheduled to be the first component of the Dow Jones Industrial Average to report third quarter when it releases results before market opens Tuesday. Analysts remain mostly upbeat on the health care and consumer products company, which has a long history of beating profit expectations.